Occudo Quantitative Strategies’s Integra LifeSciences IART Stock Holding History

Occudo Quantitative Strategies’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-42,580	Closed	-$774K	–	799
2024 Q3	$774K	Buy	+42,580	New	+$987K	0.14%	194
2024 Q1	–	Sell	-13,991	Closed	-$609K	–	875
2023 Q4	$609K	Sell	13,991 -19,071	-58%	-$751K	0.08%	331
2023 Q3	$1.26M	Buy	+33,062	New	+$1.39M	0.16%	197
2022 Q4	–	Sell	-84,848	Closed	-$3.59M	–	1153
2022 Q3	$3.59M	Buy	84,848 +55,635	+190%	+$2.85M	0.28%	76
2022 Q2	$1.58M	Sell	29,213 -3,940	-12%	-$237K	0.13%	243
2022 Q1	$2.13M	Buy	33,153 +2,047	+7%	+$135K	0.18%	160
2021 Q4	$2.08M	Buy	31,106 +7,828	+34%	+$530K	0.18%	150
2021 Q3	$1.59M	Buy	23,278 +4,061	+21%	+$287K	0.19%	130
2021 Q2	$1.31M	Buy	19,217 +9,241	+93%	+$653K	0.2%	142
2021 Q1	$689K	Buy	9,976 +668	+7%	+$45.3K	0.15%	229
2020 Q4	$604K	Buy	+9,308	New	+$501K	0.19%	183

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Occudo Quantitative Strategies's IART Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of Integra LifeSciences (IART) in Q4 2024, closing a stake of 42,580 shares — an estimated $774K sold.

Occudo Quantitative Strategies first reported a position in IART in Q4 2020 and held it in 11 quarters. The position peaked at $3.59M in Q3 2022. 223 funds tracked by Wall St. Rank hold IART as of Q4 2024.

Occudo Quantitative Strategies reported no remaining Integra LifeSciences position as of Q4 2024 after selling out during the quarter.
Occudo Quantitative Strategies sold 42,580 Integra LifeSciences shares in Q4 2024, an estimated $774K.
Occudo Quantitative Strategies first reported a position in Integra LifeSciences in Q4 2020 and held it in 11 quarters.
Occudo Quantitative Strategies's Integra LifeSciences position peaked at $3.59M in Q3 2022.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.